Akèy › Maladi kadyovaskilè › Kansas › Kansas City
Etid klinik pou Maladi kadyovaskilè nan Kansas City, KS
14 etid pou Maladi kadyovaskilè ap chèche patisipan nan sit nan ak bò kote Kansas City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
ELEVATE-HFpEF Clinical Study
Ap rekrite
- University of Kansas Medical Center, Kansas City
Product Surveillance Registry
Ap rekriteEtid obsèvasyon
- Kansas City, Kansas City
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Ap rekriteFaz 3
- Clinical Trial Site, Kansas City
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Ap rekrite
- University of Kansas Medical Center, Kansas City
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Ap rekrite
- The University Of Kansas Medical Center, Kansas City
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Ap rekriteFaz 3
- University of Kansas Hospital, Kansas City
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Ap rekriteFaz 2
- Clinical Research Site, Kansas City
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
Ap rekriteFaz 4Volontè an sante akeyi
- University of Kansas Medical Center, Kansas City
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Ap rekriteFaz 3
- Research Site, Kansas City
- Research Site, Kansas City
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Ap rekriteFaz 3
- University of Kansas Medical Center, Kansas City
The Oxford Risk Factors And Non-Invasive Imaging Study
Ap rekriteEtid obsèvasyon
- Midwest Heart & Vascular Specialists LLC, Kansas City
- St Luke's Hospital, Kansas City
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Ap rekrite
- University of Kansas Medical Center (KUMC), Kansas City
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Ap rekrite
- Kansas University Medical Center, Kansas City
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Ap rekriteFaz 1/2
- University of Kansas Medical Center, Kansas City
Etid Maladi kadyovaskilè nan lòt vil
- Boston, MA37 etid
- New York City, NY33 etid
- Washington, DC28 etid
- Houston, TX24 etid
- Dallas, TX23 etid
- Atlanta, GA22 etid
- Cleveland, OH22 etid
- Chicago, IL21 etid
- Philadelphia, PA21 etid
- Pittsburgh, PA20 etid
- St. Louis, MO20 etid
- Nashville, TN18 etid
Lòt etid nan Kansas City
- Ensifizyans kadyak13 etid
- Obèsite13 etid
- Maladi poumon entèstisyèl13 etid
- Fibroz sistik13 etid
- Kansè nan tete12 etid
- Kansè vejik12 etid
- Leksemi mieloïd egi12 etid
- Kansè pwostat12 etid
- Kansè Poumon ki pa ti selil11 etid
- Kansè poumon11 etid
- BPCO9 etid
- Asm8 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.